Cathie Wood Agios Pharmaceuticals, Inc. Transaction History

Ark Investment Management LLC

  • $10.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 12, 2018
SELL
$52.12 - $72.33 $698,355 - $969,149
-13,399 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$54.89 - $67.12 $147,434 - $180,284
2,686 Added 25.07%
13,399 $894,000
Q2 2017

Aug 11, 2017
BUY
N/A
4,267 Added 66.2%
10,713 $551,000
Q1 2017

May 15, 2017
BUY
N/A
1,891 Added 41.51%
6,446 $376,000
Q4 2016

Feb 13, 2017
BUY
N/A
4,555
4,555 $190,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email